There are several lines of evidence to suggest that the control of c-myc at the translational and posttranslational levels is critical for the molecular and biological function of c-myc. During the past project period we have found that the non-AUG-initiated c-Myc l protein is very different from the AUG- initiated c-Myc 2 protein in terms of regulation, molecular function and biological function. The synthesis of c-Myc 2 has been shown to be necessary for growth and its deregulation can lead to tumorigenesis. Also, only c-Myc 2 protein induces hyperploidy in murine erythroleukemia cells, a phenotype associated with more advanced tumorigenic cells. In contrast, c-Myc 1 protein synthesis appears to be incompatible with growth and tumorigenesis. The synthesis of c-Myc 1 is low in growing cells and becomes induced to high levels at high cell densities. Also, c-Myc 1 synthesis is lost in many lymphomas. These observations suggest that a regulated balance of these two proteins is necessary for normal growth control. To achieve the proper ratios of the two c-Myc proteins under specific growth conditions there appears to exist an unusual translational mechanism to induce c-Myc 1 synthesis which can be triggered by amino acid deprivation. In addition to differential regulation and biological properties, we have also found that the two c-Myc proteins have very different transcriptional activities through a new DNA binding sequence specific for Myc heterodimers. Finally, we have identified and characterized a cluster of interdependent phosphorylation sites in the transactivation region of the c-Myc proteins which are regulated by growth and mitogens. One of these sites is mutated in most v-Myc proteins while a new site appears to be phosphorylated by a nuclear kinase. Overall, our hypothesis is that these translational and post-translational events represent basic regulatory mechanisms which control c-myc and other similar nuclear transcription factors in culture and in the animal. To test this hypothesis this proposal will focus on the following specific aims: l) Determine the translational mechanism controlling the induction of non-AUG- initiation by amino acid deprivation in hematopoietic cells; 2) Determine whether non-AUG initiation is regulated in mice using specific myc-LacZ constructs introduced into transgenic mice; 3) Characterize novel regulated phosphorylation events of c-Myc proteins in hematopoietic cells; and 4) Determine the effects of phosphorylation on the transcriptional and biological activities of the c-Myc proteins.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047399-08
Application #
2092536
Study Section
Molecular Biology Study Section (MBY)
Project Start
1988-04-01
Project End
1997-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Vaknin, Uri A; Hann, Stephen R (2006) The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic. J Cell Biochem 97:1094-103
Hsia, Nelson; Brousal, Jeffrey P; Hann, Stephen R et al. (2005) Recapitulation of germ cell- and pituitary-specific expression with 1.6 kb of the cystatin-related epididymal spermatogenic (Cres) gene promoter in transgenic mice. J Androl 26:249-57
Gregory, Mark A; Qi, Ying; Hann, Stephen R (2005) The ARF tumor suppressor: keeping Myc on a leash. Cell Cycle 4:249-52
Gregory, Mark A; Qi, Ying; Hann, Stephen R (2003) Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606-12
Cornwall, G A; Collis, R; Xiao, Q et al. (2001) B-Myc, a proximal caput epididymal protein, is dependent on androgens and testicular factors for expression. Biol Reprod 64:1600-7
Gregory, M A; Hann, S R (2000) c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 20:2423-35
Claassen, G F; Hann, S R (2000) A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc Natl Acad Sci U S A 97:9498-503
Gregory, M A; Xiao, Q; Cornwall, G A et al. (2000) B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene 19:4886-95
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Spotts, G D; Patel, S V; Xiao, Q et al. (1997) Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17:1459-68

Showing the most recent 10 out of 23 publications